Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 32026-10-08NCT07223814

2 results · Page 1 of 1

Swipe the table sideways for more columns.

98 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AT-Linz-ORDENSKLINIKUMLinzAustria3
AU-Adelaide-FLINDERSAdelaideAustralia3
AU-Adelaide-RAHAdelaideAustralia4
AU-Birtinya-SUNSHINECOASTBirtinyaAustralia1
AU-Brisbane-PAHBrisbaneAustralia3
AU-Brisbane-RBWHBrisbaneAustralia3
AU-Camperdown-RPACamperdownAustralia3
AU-Melbourne-AUSTINMelbourneAustralia3
AU-Melbourne-MONASHMelbourneAustralia5
AU-Melbourne-PMCCMelbourneAustralia1
AU-Sydney-RNSHSydneyAustralia4
AU-Sydney-WSAHSydneyAustralia3
BE-Antwerpen-UZAAntwerpBelgium1
BE-Antwerpen-ZASAntwerpBelgium3
BE-Brugge-AZBRUGGEBrugesBelgium6
BE-Brussel-BORDETBrusselsBelgium5
BE-Bruxelles-STLUCBrusselsBelgium7
Be-Charleroi-GHDCCharleroiBelgium1
BE-Geel-STDIMPNAGeelBelgium1
BE-Gent-UZGENTGhentBelgium7
BE-Haine-Saint-Paul-JOLIMONTJolimontBelgium1
BE-Hasselt-VIRGAJESSE (Jessa Ziekenhuis)HasseltBelgium1
BE-Leuven-UZLEUVENLeuvenBelgium10
BE-Liege-CHULIEGELiègeBelgium5
BE-Liege-MONTLEGIALiègeBelgium1